Unknown

Dataset Information

0

Nonviral delivery of self-amplifying RNA vaccines.

ABSTRACT: Despite more than two decades of research and development on nucleic acid vaccines, there is still no commercial product for human use. Taking advantage of the recent innovations in systemic delivery of short interfering RNA (siRNA) using lipid nanoparticles (LNPs), we developed a self-amplifying RNA vaccine. Here we show that nonviral delivery of a 9-kb self-amplifying RNA encapsulated within an LNP substantially increased immunogenicity compared with delivery of unformulated RNA. This unique vaccine technology was found to elicit broad, potent, and protective immune responses, that were comparable to a viral delivery technology, but without the inherent limitations of viral vectors. Given the many positive attributes of nucleic acid vaccines, our results suggest that a comprehensive evaluation of nonviral technologies to deliver self-amplifying RNA vaccines is warranted.

SUBMITTER: Geall AJ 

PROVIDER: S-EPMC3437863 | biostudies-other | 2012 Sep

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Despite more than two decades of research and development on nucleic acid vaccines, there is still no commercial product for human use. Taking advantage of the recent innovations in systemic delivery of short interfering RNA (siRNA) using lipid nanoparticles (LNPs), we developed a self-amplifying RNA vaccine. Here we show that nonviral delivery of a 9-kb self-amplifying RNA encapsulated within an LNP substantially increased immunogenicity compared with delivery of unformulated RNA. This unique v  ...[more]

Similar Datasets

Unknown Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines.
| S-EPMC8412240 | biostudies-literature
Unknown Self-Amplifying RNA Viruses as RNA Vaccines.
| S-EPMC7404065 | biostudies-literature
Unknown Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles.
| S-EPMC6548422 | biostudies-literature
Unknown Self-amplifying RNA vaccines for infectious diseases.
| S-EPMC7580817 | biostudies-literature
Unknown Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines.
| S-EPMC7348957 | biostudies-literature
Unknown Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ.
| S-EPMC4494232 | biostudies-literature
Unknown Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids.
| S-EPMC6023837 | biostudies-literature
Unknown Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
| S-EPMC6453513 | biostudies-literature
Unknown Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice.
| S-EPMC8129084 | biostudies-literature
Unknown Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma.
| S-EPMC8563967 | biostudies-literature